期刊文献+

霉酚酸酯联合激素及低分子肝素治疗难治性肾病综合征 被引量:4

下载PDF
导出
摘要 目的:观察和探讨联合应用霉酚酸酯、激素及低分子肝素治疗难治性肾病综合征的临床疗效。方法:16例难治性肾病综合征患者采用霉酚酸酯0.75g口服q12h,3个月后减至0.5gq12h,共6个月;泼尼松(或泼尼松龙)40~50mg/日口服,8~12周渐减至5~10mg/日维持;低分子肝素钠5000IU皮下注射q12h,共用4周。结果:6个月后完全缓解5例,显著缓解6例,部分缓解3例,无效2例,显著缓解率68.75%,总有效率87.50%。结论:霉酚酸酯、激素及低分子肝素三联治疗难治性肾病综合征具有良好的疗效,且不良反应较轻。
出处 《中国社区医师(医学专业)》 2011年第10期146-146,共1页
  • 相关文献

参考文献3

二级参考文献13

  • 1Briggs WA, Choi MJ, Scheel PJ. Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis, 1998,31: 213-217.
  • 2Chan TM, Li FK, Tang CS, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med, 2000,343:1156-1162.
  • 3Austin Ⅲ HA, Muenz LR, Joyce KM, et al. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int, 1984,25: 689.
  • 4Wang W, Nolan C, Chan L. Effects of mycophenolic acid on vascular smooth muscle cell and mesangial cell proliferation. J Am Soc Nephrol, 1997,8: 669A.
  • 5Baer PC, Gauer S, Hauser IA, et al. Effects of mycophenolic acid on human renal proximal and distal tubular cells in vitro. Nephrol Dial Transplant, 2000,15:184-190.
  • 6Ziswiler R, Steinmann-Niggli K, Kappeler A, et al. Mycophenolic acid: A new approach to the therapy of experimental mesangial proliferative glomerulonephritis. J Am Soc Nephrol, 1998, 9:2055-2066.
  • 7Badid C, Vincent M, Mcgregor B, et al. Mycophenolate mofetil reduces myofibroblast infiltration and collagen Ⅲ deposition in rat remnant kidney. Kidney Int,2000,58: 51-61.
  • 8Pichler R, Giachelli CM, Lombardi D, et al. Tubulointerstitial disease in glomerulonephritis: potential role of osteopontin(uropontin). Am J Pathol, 1994, 144: 915-926.
  • 9Ophascharoensuk V, Giachelli CM, Gordon K, et al. Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int, 1999,56: 571-580.
  • 10Yang NS, Wu LL, Nikolic-Paterson DJ, et al. Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney. Nephrol Dial Transplant, 1998,13: 1967-1974.

共引文献22

同被引文献38

  • 1Allison AC,Eugui EM. Mycophenolate acid and brequinar,inhibitors of purine and pyrimidine synthesis,block the glycosylation of adhesion molecules[J].Immunopharmacology,2000,(03):85-88.
  • 2Aragon E,Chan YH,Ng KH. Good outcomes with mycophenolate-cyclosporine-based induction protocol in children with severe proliferative lupus nephritis[J].Lupus,2010,(08):965-973.
  • 3Touma Z,Gladman DD,Urowitz MB. Mycophenolate mofetil for induction treatment of lupus nephritis:a systematic review and meta analysis[J].Journal of Rheumatology,2011,(01):69-78.
  • 4Houssiau FA,Cruz D,Sangle S. Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis:results from the maintain nephritis trial[J].Annals of the Rheumatic Diseases,2010,(12):2083-2089.
  • 5Laskari K,Mavragani CP,Tzioufas AG. Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis:a long-term observational prospective study[J].Arthritis Research & Therapy,2010,(06):208.
  • 6Ginzler EM,Wofsy D,Isenberg D. Nonrenal disease activity following mycophenolate mofetil orintravenous cyclophosphamide as induction treatment for lupus nephritis[J].Arthritis and Rheumatism,2010,(01):211-222.
  • 7柯琳,栾江威,李韬.低分子肝素钙在儿童原发性肾病综合征治疗中的作用[J].华中医学杂志,2008,32(2):128-129. 被引量:7
  • 8张日文,卫学坚.吗替麦考酚酯联合糖皮质激素治疗难治性特发性血小板减少性紫癜[J].广东医学,2009,30(1):128-129. 被引量:10
  • 9张改连,黄烽,郝慧琴.吗替麦考酚酯治疗难治性自身免疫性肝病的临床研究[J].中华风湿病学杂志,2009,13(2):114-116. 被引量:5
  • 10朱云海,李奕龙,廖凤,陈家勇.难治性肾病综合征临床综合治疗观察[J].中国医学创新,2009,6(24):52-53. 被引量:5

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部